Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma
Crossref DOI link: https://doi.org/10.1007/s00280-017-3486-3
Published Online: 2017-12-08
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mistry, Hitesh B. http://orcid.org/0000-0002-9683-1903
Orrell, David
Eftimie, Raluca
License valid from 2017-12-08